- Home
- ANET vs BMY Comparison
ANET vs BMY Comparison
Compare ANET & BMY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ANET
- BMY
- Stock Information
- Founded
- ANET 2004
- BMY 1887
- Country
- ANET United States
- BMY United States
- Employees
- ANET N/A
- BMY N/A
- Industry
- ANET Computer Communications Equipment
- BMY Biotechnology: Pharmaceutical Preparations
- Sector
- ANET Telecommunications
- BMY Health Care
- Exchange
- ANET Nasdaq
- BMY Nasdaq
- Market Cap
- ANET 117.3B
- BMY 120.5B
- IPO Year
- ANET 2014
- BMY N/A
- Fundamental
- Price
- ANET $73.55
- BMY $51.34
- Analyst Decision
- ANET Strong Buy
- BMY Hold
- Analyst Count
- ANET 16
- BMY 15
- Target Price
- ANET $105.92
- BMY $57.79
- AVG Volume (30 Days)
- ANET 12.8M
- BMY 13.7M
- Earning Date
- ANET 05-06-2025
- BMY 04-24-2025
- Dividend Yield
- ANET N/A
- BMY 4.75%
- EPS Growth
- ANET 35.15
- BMY N/A
- EPS
- ANET 2.23
- BMY N/A
- Revenue
- ANET $7,003,146,000.00
- BMY $48,300,000,000.00
- Revenue This Year
- ANET $21.35
- BMY N/A
- Revenue Next Year
- ANET $17.83
- BMY N/A
- P/E Ratio
- ANET $33.00
- BMY N/A
- Revenue Growth
- ANET 19.50
- BMY 7.32
- 52 Week Low
- ANET $59.43
- BMY $39.35
- 52 Week High
- ANET $133.58
- BMY $63.33
- Technical
- Relative Strength Index (RSI)
- ANET 41.76
- BMY 30.05
- Support Level
- ANET $59.43
- BMY $48.82
- Resistance Level
- ANET $77.65
- BMY $55.77
- Average True Range (ATR)
- ANET 5.21
- BMY 2.31
- MACD
- ANET 0.45
- BMY -0.98
- Stochastic Oscillator
- ANET 53.07
- BMY 19.62
About ANET Arista Networks Inc.
Arista Networks is a networking equipment provider that primarily sells Ethernet switches and software to data centers. Its marquee product is its extensible operating system, or EOS, that runs a single image across every single one of its devices. The firm operates as one reportable segment. It has steadily gained market share since its founding in 2004, with a focus on high-speed applications. Arista counts Microsoft and Meta Platforms as its largest customers and derives roughly three quarters of its sales from North America.
About BMY Bristol-Myers Squibb Company
Bristol-Myers Squibb discovers, develops, and markets drugs for various therapeutic areas, such as cardiovascular, cancer, and immune disorders. A key focus for Bristol is immuno-oncology, where the firm is a leader in drug development. Bristol derives close to 70% of total sales from the US, showing a higher dependence on the US market than most of its peer group.